Unlock instant, AI-driven research and patent intelligence for your innovation.

Therapeutic microvesicles of probiotic bacteria

A probiotic, therapeutic technology, applied in the field of therapeutic microbubbles, can solve the problem that the time of emergence is not immediate

Pending Publication Date: 2021-12-03
BIOGAIA AB
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the onset of this effect is not immediate and it may take one to three weeks before the infant benefits from the treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Therapeutic microvesicles of probiotic bacteria
  • Therapeutic microvesicles of probiotic bacteria
  • Therapeutic microvesicles of probiotic bacteria

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0158] Example 1 - Altered enzymatic activity associated with MV production

[0159]Lactobacillus reuteri DSM 17938 was cultured and subjected to different inducing treatments at specific time points. Responses to these inducing treatments were determined using enzymatic assays and compared to the responses obtained with control treatments. The inductive treatment involves inducing stress to the bacteria during their growth phase and then measuring the effect on enzymatic activity in the bacterial conditioned medium.

[0160] Materials and Methods

[0161] Culture / Sample Collection

[0162] Lactobacillus reuteri DSM 17938 was inoculated from a frozen stock into 25 mL of de Man-Rogosa-Sharpe (MRS) medium under normal culture conditions, ie anaerobically grown overnight at 37°C. Bacteria (20 mL) were then re-inoculated into 200 mL MRS, and different inducing treatments were applied, as described in more detail below. Bacterial samples at 5000 x g Centrifuge for 10 min, tr...

Embodiment 2

[0179] Example 2 - Specific culture conditions are associated with increased MV production

[0180] L. reuteri DSM 17938 was cultured and subjected to different inducing treatments. The amount of MV produced as a result of these inductive treatments was determined using Nanoparticle Tracking Analysis (NTA), and the results were compared to the responses obtained with control treatments. Inductive treatments involved oxygen treatment and sucrose treatment, and the effect on MV production was measured in bacterial conditioned media.

[0181] Materials and Methods

[0182] oxygen treatment

[0183] Lactobacillus reuteri DSM 17938 was cultured under normal culture conditions, i.e. anaerobically in bottles / flasks at 37°C in de Man-Rogosa-Sharpe (MRS) medium. Oxygen treatment was induced by vigorous shaking of the bacterial culture for 24 hours. As a control, Lactobacillus reuteri DSM 17938 was cultured under normal culture conditions, i.e. anaerobic culture in MRS medium at 3...

Embodiment 3

[0195] Example 3 - Isolated Bacterial Microvesicles Recapitulate Bacterial Effects on Intestinal Motility

[0196] Materials and Methods

[0197] animal

[0198] Adult male Swiss Webster mice (6-8 weeks) were obtained from Charles River Laboratories (Wilmington, MA, USA). Animals were housed 4-5 / cage under a 12 hour light / dark cycle and provided food and water ad libitum. Subsequent procedures following cervical dislocation were performed in vitro according to the McMaster Animal Ethics Research Board (AREB) (permit 16-08-30).

[0199] Tissue Flotation Bath Records

[0200]Tissue flotation bath recordings were performed as described in Wu et al. (2013). Jejunum and colon segments with a minimum length of 4 cm were extracted and fixed in a 20 mL tissue flotation bath filled with oxygenated Krebs at 34°C. The buccal end of the segment was cannulated and the contents flushed from the lumen by gravity perfusion of Krebs inflated with carbon gas using a Mariotte bottle. O...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method to provide therapeutic microvesicles from probiotic bacteria comprises exposing the bacteria to an inducing treatment during culturing to induce production of therapeutic microvesicles by the bacteria. The therapeutic microvesicles may be used in treatment of, for instance, colic, an infant or childhood gastrointestinal disorder or disease, a gastrointestinal pain disorder, a bone loss disease and / or a periodontal disease.

Description

technical field [0001] The present invention generally relates to therapeutic microvesicles of probiotics and uses thereof. Background technique [0002] The Food and Agricultural Organization of the United Nations has defined probiotics as "live microorganisms that, when administered in sufficient amounts, confer a health benefit on the host". Probiotics affect host immune function via modulation of microbiota composition, via metabolic activity, or even via direct interaction with the immune system underlying the intestinal mucosa. More than 60% of immune cells are located in the intestinal mucosa, and sampling information on microbiota structure and composition is translated into local and systemic effects by circulating immune cells. Following probiotic interaction, immune mechanisms may be activated, as reflected by release of immune mediators such as cytokines, production of antibodies, and activation of lymphocytes and other immune cells. These activated cells, cyto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/745A61K35/747A61P1/00C12N1/00
CPCA61K35/745A61K35/747A61P1/00C12N1/20C12R2001/01C12N1/205A61K2300/00A61P1/14A61P19/10C12N1/04
Inventor S·鲁斯W·昆泽J·别南斯托克
Owner BIOGAIA AB